Sign Out
Hypersensitivity to the active substance or to any of the excipients listed in Description (see Precautions).
Severe IgA deficiency and a history of hypersensitivity to human immunoglobulin treatment.
Cuvitru must not be given intravascularly or intramuscularly.
